Our business models

CRO model with target exclusivity

In the CRO-type partnership we provide target-exclusive services to customers from the pharmaceutical industry. The project IP is fully owned by the customer. 

Structure based drug discovery of leadXpro therapeutics

In the biotech business model we generate and characterize drug candidates for partnering with pharmaceutical companies in clinical research. Therapeutic areas are oncology, inflammation and antibiotics.

Flexible models to fit your purpose

  • Project centered long term collaboration
  • leadXpro complements your technologies and capabilites
  • From gene over lead compound discovery to clinical candidate

This website is using cookies. If you continue to use this site you agree to our privacy policy. Our privacy policy